Which has grown faster, NTRA or REGN?

Over the past five years, NTRA grew revenue faster — NTRA at a 39.92% CAGR versus REGN at 4.64%.

Does NTRA or REGN pay a bigger dividend?

REGN pays a dividend (0.50% yield), while NTRA has no payments in the available dividend history.

Is NTRA or REGN more profitable?

REGN runs the higher net margin — NTRA at -7.11% versus REGN at 27.86%.

How have NTRA and REGN total returns compared?

Over the past 10 years, NTRA delivered 43.44% and REGN delivered 6.32% annualized total return. Past performance doesn't predict future results.

Natera, Inc. (NTRA) vs Regeneron Pharmaceuticals, Inc. (REGN)

A side-by-side comparison of Natera, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

NTRA

Natera, Inc.

$58.77B

$410.35HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

REGN

Regeneron Pharmaceuticals, Inc.

$75.74B

$735.20HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — NTRA vs REGN

growth of $100 · dividends reinvested · last 10y

NTRA +3630.5% (+43.6%/yr)REGN +77.1% (+5.9%/yr)NTRA compounded faster over this window

Log scale — wide-divergence pair

NTRA REGN

NTRA vs REGN: by the numbers

•REGN is the larger company ($75.74B vs $58.77B market cap).
•REGN is profitable (27.86% net margin) while NTRA runs a net loss (-7.11%).
•NTRA grew revenue faster over the past five years (39.92% vs 4.64% CAGR).
•REGN pays a dividend (0.50% yield), while NTRA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	NTRA	REGN
P/E ratio	N/A	18.18
Forward P/E	N/A	13.24
PEG ratio	N/A	2.87
P/S ratio	21.71	4.88
P/B ratio	32.26	2.39
EV / EBITDA	N/A	16.73
FCF yield	0.12%	4.65%

Profitability

Metric	NTRA	REGN
Gross margin	65.30%	84.86%
Operating margin	-10.70%	25.56%
Net margin	-7.11%	27.86%
ROE	-10.56%	13.65%
ROIC	-13.26%	9.19%

Dividends

Metric	NTRA	REGN
Dividend yield	N/A	0.50%
Payout ratio	N/A	9.15%

Growth (annualized)

Metric	NTRA	REGN
Revenue CAGR (5Y)	39.92%	4.64%
EPS CAGR (5Y)	N/A	5.70%
FCF CAGR (5Y)	N/A	15.77%
Total return CAGR (5Y)	29.55%	5.38%

Frequently asked

Which has grown faster, NTRA or REGN?: Over the past five years, NTRA grew revenue faster — NTRA at a 39.92% CAGR versus REGN at 4.64%.
Does NTRA or REGN pay a bigger dividend?: REGN pays a dividend (0.50% yield), while NTRA has no payments in the available dividend history.
Is NTRA or REGN more profitable?: REGN runs the higher net margin — NTRA at -7.11% versus REGN at 27.86%.
How have NTRA and REGN total returns compared?: Over the past 10 years, NTRA delivered 43.44% and REGN delivered 6.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NTRA analysis Full REGN analysis Interactive comparison tool

Dig into the metrics

Regeneron Pharmaceuticals P/E ratio Regeneron Pharmaceuticals dividend yield Natera ROE Regeneron Pharmaceuticals ROE Natera operating margin Regeneron Pharmaceuticals operating margin Natera revenue growth Regeneron Pharmaceuticals revenue growth Natera free cash flow Regeneron Pharmaceuticals free cash flow

Natera & Regeneron Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.